These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7505413)

  • 1. Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
    Saigo A; Takano Y; Matsumoto T; Tran M; Nakayama Y; Saito R; Yamada K; Kamiya H
    Neurosci Lett; 1993 Sep; 159(1-2):187-90. PubMed ID: 7505413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus.
    Eguchi T; Takano Y; Hatae T; Saito R; Nakayama Y; Shigeyoshi Y; Okamura H; Krause JE; Kamiya H
    Brain Res; 1996 Dec; 743(1-2):49-55. PubMed ID: 9017229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus.
    Nakayama Y; Takano Y; Saito R; Kamiya H
    Brain Res; 1992 Nov; 595(2):339-42. PubMed ID: 1281741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin B signaling in the female rat: a novel link between stress and reproduction.
    Grachev P; Li XF; Hu MH; Li SY; Millar RP; Lightman SL; O'Byrne KT
    Endocrinology; 2014 Jul; 155(7):2589-601. PubMed ID: 24708241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of central tachykinin peptides in cardiovascular regulation in rats.
    Takano Y; Nagashima A; Hagio T; Tateishi K; Kamiya H
    Brain Res; 1990 Oct; 528(2):231-7. PubMed ID: 1703026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
    Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
    Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin NK(3)receptor involvement in anxiety.
    Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC
    Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal neurokin3 receptors facilitate the nociceptive flexor reflex via a pathway involving nitric oxide.
    Linden DR; Jia YP; Seybold VS
    Pain; 1999 Mar; 80(1-2):301-8. PubMed ID: 10204743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine.
    Bealer SL; Flynn FW
    Exp Neurol; 2003 Dec; 184(2):1027-33. PubMed ID: 14769397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.
    Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
    J Endocrinol; 1994 Nov; 143(2):227-34. PubMed ID: 7829988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist.
    Yamamura Y; Ogawa H; Yamashita H; Chihara T; Miyamoto H; Nakamura S; Onogawa T; Yamashita T; Hosokawa T; Mori T
    Br J Pharmacol; 1992 Apr; 105(4):787-91. PubMed ID: 1387020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
    Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
    Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
    Roccon A; Marchionni D; Nisato D
    Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
    Altier N; Stewart J
    Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization.
    Yuan YD; Couture R
    Br J Pharmacol; 1997 Mar; 120(5):785-96. PubMed ID: 9138683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.
    Ukai M; Shinkai N; Kameyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):97-101. PubMed ID: 8905797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.